Ratings by Goldman Sachs (Madhu Kumar)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/1/2022 Iovanace Biotherapeutics IOVA Maintain Buy
(N/A)
 
 
  Details
6/7/2022 Arrowhead Pharma ARWR Maintain Buy
(N/A)
 
 
  Details
5/17/2022 Magenta Therapeutics MGTA Maintain Buy
(N/A)
 
 
  Details
5/11/2022 Edgewise Therapeutics EWTX Maintain Neutral
(N/A)
 
 
  Details
5/10/2022 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
5/9/2022 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
5/5/2022 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
5/5/2022 Jazz Pharmaceuticals JAZZ Maintain Neutral
(N/A)
 
 
  Details
5/5/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
5/4/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
4/13/2022 Tricida TCDA New Coverage Buy
(N/A)
9.64
(9.64)
0% Details
4/13/2022 Alector Inc. ALEC New Coverage Sell
(N/A)
12.28
(11.02)
-10.26% Details
4/6/2022 Jazz Pharmaceuticals JAZZ Downgrade Neutral
(Buy)
160.73
(158.58)
-1.34% Details
3/24/2022 Reata Pharmaceuticals RETA New Coverage Buy
(N/A)
37.09
(30.44)
-17.93% Details
3/15/2022 Design Therapeutics Inc DSGN Maintain Sell
(N/A)
 
 
  Details
3/8/2022 Magenta Therapeutics MGTA Maintain Buy
(N/A)
 
 
  Details
3/3/2022 Passage Bio Inc. PASG Maintain Neutral
(N/A)
 
 
  Details
3/2/2022 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
3/2/2022 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Cerevel Therapeutics CERE Maintain
(Neutral)
 
 
  Details
3/1/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Arcturus Therapeutics ARCT Maintain Sell
(N/A)
 
 
  Details
3/1/2022 Dynavax Technologies DVAX Maintain Buy
(N/A)
 
 
  Details
2/28/2022 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
2/28/2022 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
2/25/2022 Iovanace Biotherapeutics IOVA Maintain Buy
(N/A)
 
 
  Details
2/24/2022 Editas Medicine EDIT Maintain Sell
(N/A)
 
 
  Details
2/15/2022 Cerevel Therapeutics CERE New Coverage Neutral
(N/A)
30.63
(26.42)
-13.74% Details
2/15/2022 Syndax Pharmaceuticals SNDX New Coverage Buy
(N/A)
14.98
(19.07)
27.3% Details
1/28/2022 Edgewise Therapeutics EWTX New Coverage Neutral
(N/A)
14.00
(8.08)
-42.29% Details
1/28/2022 Cytokinetics CYTK New Coverage Buy
(N/A)
30.24
(41.00)
35.58% Details
1/19/2022 Arrowhead Pharma ARWR New Coverage Buy
(N/A)
57.81
(35.96)
-37.8% Details
1/19/2022 Passage Bio Inc. PASG New Coverage Neutral
(N/A)
5.76
(2.38)
-58.68% Details
1/19/2022 TCR2 Therapeutics TCRR New Coverage Neutral
(N/A)
4.01
(2.89)
-27.93% Details
1/19/2022 Design Therapeutics Inc DSGN New Coverage Sell
(N/A)
15.85
(14.09)
-11.1% Details
1/19/2022 Arvinas Inc. ARVN New Coverage Buy
(N/A)
67.42
(42.58)
-36.84% Details
1/6/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
1/6/2022 Dynavax Technologies DVAX New Coverage Buy
(N/A)
13.40
(12.96)
-3.28% Details
1/6/2022 Magenta Therapeutics MGTA Upgrade Buy
(Neutral)
4.77
(1.31)
-72.54% Details
11/29/2021 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
11/19/2021 Jazz Pharmaceuticals JAZZ New Coverage Buy
(N/A)
133.09
(158.58)
19.15% Details
11/19/2021 Horizon Therapeutics HZNP Upgrade Buy
(Neutral)
108.08
(80.84)
-25.2% Details
11/12/2021 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
11/10/2021 Dicerna Pharmaceuticals DRNA Maintain Neutral
(N/A)
 
 
  Details
11/9/2021 Arcturus Therapeutics ARCT Maintain Sell
(N/A)
 
 
  Details
11/5/2021 Iovanace Biotherapeutics IOVA Maintain Buy
(N/A)
 
 
  Details
10/27/2021 Myovant Sciences Ltd. MYOV Maintain Neutral
(N/A)
 
 
  Details
9/13/2021 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
8/27/2021 Applied Therapeutics APLT Downgrade Sell
(Neutral)
17.44
(0.87)
-95.01% Details
8/20/2021 Myovant Sciences Ltd. MYOV New Coverage Neutral
(N/A)
20.97
(12.96)
-38.2% Details
8/20/2021 Magenta Therapeutics MGTA New Coverage Neutral
(N/A)
6.16
(4.77)
-22.56% Details
8/11/2021 Dicerna Pharmaceuticals DRNA Downgrade Neutral
(Buy)
23.83
(38.22)
60.39% Details
8/11/2021 Arcturus Therapeutics ARCT Downgrade Sell
(Neutral)
48.24
(16.16)
-66.5% Details
8/10/2021 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
8/6/2021 Dicerna Pharmaceuticals DRNA Maintain Buy
(N/A)
 
 
  Details
8/6/2021 Dynavax Technologies DVAX New Coverage Buy
(N/A)
9.88
(13.40)
35.63% Details
7/20/2021 Krystal Biotech KRYS Upgrade Buy
(Neutral)
61.09
(67.47)
10.44% Details
6/25/2021 Arcturus Therapeutics ARCT New Coverage Neutral
(N/A)
34.03
(16.16)
-52.51% Details
6/25/2021 Applied Therapeutics APLT New Coverage Neutral
(N/A)
25.04
(17.44)
-30.35% Details
5/21/2021 Iovanace Biotherapeutics IOVA Maintain Buy
(N/A)
 
 
  Details
5/19/2021 Iovanace Biotherapeutics IOVA Maintain Buy
(Buy)
 
 
  Details
5/17/2021 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
5/13/2021 Editas Medicine EDIT Maintain Sell
(N/A)
 
 
  Details
5/10/2021 Krystal Biotech KRYS Maintain Neutral
(N/A)
 
 
  Details
4/16/2021 Editas Medicine EDIT New Coverage Sell
(N/A)
41.53
(12.59)
-69.68% Details
4/16/2021 Iovanace Biotherapeutics IOVA New Coverage Buy
(N/A)
29.99
(11.47)
-61.75% Details
4/16/2021 Dicerna Pharmaceuticals DRNA New Coverage Buy
(N/A)
27.83
(38.22)
37.33% Details
4/16/2021 Apellis Pharmaceuticals APLS New Coverage Buy
(N/A)
44.48
(45.43)
2.14% Details